{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:22:23Z","timestamp":1790702543451,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","award":["PIP 516"],"award-info":[{"award-number":["PIP 516"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CODDIM Ile-de-France"},{"DOI":"10.13039\/501100005737","name":"University of Pierre and Marie Curie (UPMC)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005363","name":"University of Buenos Aires","doi-asserted-by":"publisher","award":["UBACyT CB23"],"award-info":[{"award-number":["UBACyT CB23"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Craveri Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.bbalip.2016.10.014","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T04:16:36Z","timestamp":1478060196000},"page":"188-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c"],"prefix":"10.1016","volume":"1862","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4196-2391","authenticated-orcid":false,"given":"Leonardo","family":"Gomez Rosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-3494","authenticated-orcid":false,"given":"Tomas","family":"Mero\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Dellepiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sorroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyamine","family":"Hedjazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Zakiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Sukhorukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Gasparri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. John","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Kontush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9438","key":"10.1016\/j.bbalip.2016.10.014_bb0005","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"12A","key":"10.1016\/j.bbalip.2016.10.014_bb0010","doi-asserted-by":"crossref","first-page":"11L","DOI":"10.1016\/S0002-9149(00)01462-4","article-title":"The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease","volume":"86","author":"Maron","year":"2000","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.bbalip.2016.10.014_bb0015","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bbalip.2016.10.014_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jacc.2003.08.061","article-title":"Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update","volume":"43","author":"Gotto","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2016.10.014_bb0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbalip.2016.10.014_bb0030","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.bbalip.2016.10.014_bb0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.bbalip.2016.10.014_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ncpcardio0500","article-title":"Antiatherogenic small, dense HDL\u2014guardian angel of the arterial wall?","volume":"3","author":"Kontush","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.bbalip.2016.10.014_bb0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.bbalip.2016.10.014_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11883-006-0026-8","article-title":"Alterations in lipoprotein defense against oxidative stress in metabolic syndrome","volume":"8","author":"Hansel","year":"2006","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.bbalip.2016.10.014_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","article-title":"Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia","volume":"48","author":"Nobecourt","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bbalip.2016.10.014_bb0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11892-008-0010-5","article-title":"Why is HDL functionally deficient in type 2 diabetes?","volume":"8","author":"Kontush","year":"2008","journal-title":"Curr. Diab. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2016.10.014_bb0065","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","author":"American","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ab.2008.05.002","article-title":"Impact of freezing on high-density lipoprotein functionality","volume":"379","author":"Kekulawala","year":"2008","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.bbalip.2016.10.014_bb0075","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.ATV.13.6.815","article-title":"Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects","volume":"13","author":"Lagrost","year":"1993","journal-title":"Arterioscler. Thromb."},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0006-291X(83)91778-3","article-title":"Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats","volume":"113","author":"Blank","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.bbalip.2016.10.014_bb0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.ATV.16.6.763","article-title":"Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia","volume":"16","author":"Guerin","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0021-9150(02)00037-0","article-title":"Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux","volume":"163","author":"Guerin","year":"2002","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.bbalip.2016.10.014_bb0100","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2005.03.001","article-title":"A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity","volume":"182","author":"Kontush","year":"2005","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.bbalip.2016.10.014_bb0110","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bbalip.2016.10.014_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","article-title":"Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity","volume":"197","author":"de Souza","year":"2008","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2016.10.014_bb0125","series-title":"Atlanta GUSDoHaHS. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States","author":"Centers for Disease Control and Prevention","year":"2011"},{"issue":"19","key":"10.1016\/j.bbalip.2016.10.014_bb0130","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1021\/bi992902m","article-title":"The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study","volume":"39","author":"Curtiss","year":"2000","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bbalip.2016.10.014_bb0135","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00125-006-0244-1","article-title":"Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation","volume":"49","author":"Persegol","year":"2006","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.bbalip.2016.10.014_bb0140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.285.12.1585","article-title":"Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial","volume":"285","author":"Robins","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bbalip.2016.10.014_bb0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.atherosclerosis.2014.09.034","article-title":"Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation","volume":"237","author":"Gomez Rosso","year":"2014","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.bbalip.2016.10.014_bb0150","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.bbalip.2013.07.009","article-title":"Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles","volume":"1831","author":"Stahlman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bbalip.2016.10.014_bb0155","doi-asserted-by":"crossref","first-page":"e62885","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2014a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbalip.2016.10.014_bb0160","doi-asserted-by":"crossref","first-page":"e74341","DOI":"10.1371\/journal.pone.0074341","article-title":"Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes","volume":"8","author":"Meikle","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbalip.2016.10.014_bb0165","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00125-015-3587-7","article-title":"The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics","volume":"58","author":"Lappas","year":"2015","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bbalip.2016.10.014_bb0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/BJ20101867","article-title":"A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking","volume":"435","author":"Boslem","year":"2011","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bbalip.2016.10.014_bb0175","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/en.2014-1467","article-title":"Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine","volume":"156","author":"Manukyan","year":"2015","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bbalip.2016.10.014_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/isl.20102","article-title":"Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction","volume":"4","author":"Boslem","year":"2012","journal-title":"Islets"},{"issue":"1","key":"10.1016\/j.bbalip.2016.10.014_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198116303018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198116303018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:10:26Z","timestamp":1657584626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198116303018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1388198116303018"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2016.10.014","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2016.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}